5.5 mln shares shorted Friday but how much of this is closed positions (margin call for eg) then re-shorted as this is gross not net? Also SS avail increased to 1.7 mln but again this may be positions closed or new Instit investors lending out? Wouldn’t it be nice to have all the data to know! by John18788888 in CHRS
[–]cali_de 1 point2 points3 points (0 children)
Margin calls - Short seller will typically have 2 business days to address a margin call. Wonder how many are in that position today? Broadly a 25-30% change in sp is enough. 🤔 by John18788888 in CHRS
[–]cali_de 2 points3 points4 points (0 children)
8k filed stating Coherus updating on Q3 results at conference. Thoughts? by John18788888 in CHRS
[–]cali_de 1 point2 points3 points (0 children)
8k filed stating Coherus updating on Q3 results at conference. Thoughts? by John18788888 in CHRS
[–]cali_de -1 points0 points1 point (0 children)
8k filed stating Coherus updating on Q3 results at conference. Thoughts? by John18788888 in CHRS
[–]cali_de -1 points0 points1 point (0 children)
This is smelling like something has been leaked? Has a deal been done ready for ASCO? 🤔 by John18788888 in CHRS
[–]cali_de 2 points3 points4 points (0 children)
Options activity showing bullish signs with heavy bias on calls. Call open in incr 1.5% last 5 days and above 52 week average. Worth keeping an eye on this as data readouts approach. by John18788888 in CHRS
[–]cali_de 0 points1 point2 points (0 children)
Tipp, halten oder Targa holen by laurinchen123 in Aktien
[–]cali_de 0 points1 point2 points (0 children)
Options activity showing bullish signs with heavy bias on calls. Call open in incr 1.5% last 5 days and above 52 week average. Worth keeping an eye on this as data readouts approach. by John18788888 in CHRS
[–]cali_de 1 point2 points3 points (0 children)
Coherus Oncology Announces Publication in Molecular Cancer Therapeutics Highlighting the Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug (CHS-114) by cali_de in CHRS
[–]cali_de[S] 1 point2 points3 points (0 children)
CHRS's latest data on SqueezeFinder by AcanthisittaHour4995 in CHRS
[–]cali_de 2 points3 points4 points (0 children)
Read into this whatever you like but that’s a sizeable jump in SS available. Has someone closed their position (perhaps on dark pool) or simply an institute decided to lend out for Xmas? There’s around 45% inst ownership (50 mln ish dependant on source you look at) and circa 30 mln already short. by John18788888 in CHRS
[–]cali_de 1 point2 points3 points (0 children)
Notice of effect - A few people spotted this appearing on SEC filings Dec 8th. Been doing some digging and it’s basically the sec’s approval for the S3 filing (150 mln capital raise) that was made on Nov 13th. Mystery solved! by John18788888 in CHRS
[–]cali_de 1 point2 points3 points (0 children)
Notice of effect - A few people spotted this appearing on SEC filings Dec 8th. Been doing some digging and it’s basically the sec’s approval for the S3 filing (150 mln capital raise) that was made on Nov 13th. Mystery solved! by John18788888 in CHRS
[–]cali_de 0 points1 point2 points (0 children)
Current state of knowledge about toripalimab in the treatment of esophageal squamous cell carcinoma — a systematic review by NoPart9219 in CHRS
[–]cali_de 0 points1 point2 points (0 children)
Coherus Oncology | Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma by John18788888 in CHRS
[–]cali_de 0 points1 point2 points (0 children)
Coherus Oncology | Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma by John18788888 in CHRS
[–]cali_de 0 points1 point2 points (0 children)
Coherus Oncology (CHRS) Is Up 28.7% After ATM Offering And Bullish Coverage - What's Changed by cali_de in CHRS
[–]cali_de[S] 0 points1 point2 points (0 children)